Brokerages Set Sotera Health (NASDAQ:SHC) Target Price at $16.08

Shares of Sotera Health (NASDAQ:SHC) have been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $16.08.

Several analysts have recently issued reports on the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. Citigroup increased their price objective on Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, November 6th. The Goldman Sachs Group assumed coverage on Sotera Health in a research note on Friday, December 6th. They issued a “neutral” rating and a $14.00 price objective on the stock. Finally, Barclays reduced their price objective on Sotera Health from $18.00 to $17.00 and set an “overweight” rating on the stock in a research note on Tuesday, February 18th.

Sotera Health Stock Down 0.4 %

NASDAQ:SHC opened at $13.47 on Friday. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The stock’s fifty day moving average is $13.46 and its two-hundred day moving average is $14.55. Sotera Health has a 52 week low of $10.71 and a 52 week high of $17.44. The stock has a market capitalization of $3.82 billion, a price-to-earnings ratio of 53.88 and a beta of 1.91.

Hedge Funds Weigh In On Sotera Health

Several large investors have recently bought and sold shares of the business. Blue Trust Inc. grew its holdings in shares of Sotera Health by 164.3% during the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after purchasing an additional 1,140 shares during the last quarter. Quarry LP purchased a new position in shares of Sotera Health during the fourth quarter worth about $28,000. True Wealth Design LLC purchased a new position in shares of Sotera Health during the third quarter worth about $32,000. GAMMA Investing LLC grew its holdings in shares of Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after purchasing an additional 1,121 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Sotera Health by 37.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock worth $82,000 after purchasing an additional 1,640 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.